Beta Bionics (BBNX) Income from Continuing Operations (2024 - 2026)
Beta Bionics (BBNX) posted Income from Continuing Operations of 64363000.0 for Q2 2026, down 47.5% sequentially from 43637000.0 in Q1 2026, and down 6.02% YoY from 68487574.99 in Q2 2025.
Beta Bionics (BBNX) Income from Continuing Operations (2024 - 2026) Analysis & Trends
Beta Bionics has reported Income from Continuing Operations for 3 years, with the latest figure at 64363000.0 in Q2 2026.
- Quarterly Income from Continuing Operations fell 6.02% year-over-year to 64363000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 205029000.0 (down 39.89% YoY) and the FY2025 annual result came in at 202674000.0, down 97.99% from the prior year.
- Income from Continuing Operations fell to 64363000.0 in Q2 2026 per BBNX's latest filing, from 43637000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 8814000.0 in Q1 2024 and troughed at 82763000.0 in Q3 2025.
- A 3-year average of 37169700.0 and a median of 28951500.0 in 2025 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2025 and 2026: Income from Continuing Operations plunged 669.82% in 2025, then surged 30.09% in 2026.
- Over 3 years, Income from Continuing Operations stood at 12686000.0 in 2024, then decreased by 12.45% to 14266000.0 in 2025, then plunged by 351.16% to 64363000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 64363000.0, 43637000.0, and 14266000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Beta Bionics | 842.80 Mn | 662.31 Mn | 18.90 Mn | -23.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -64.36 Mn |
| Mar 31, 2026 | -43.64 Mn |
| Dec 31, 2025 | -14.27 Mn |
| Sep 30, 2025 | -82.76 Mn |
| Jun 30, 2025 | -60.71 Mn |
| Mar 31, 2025 | -62.42 Mn |
| Dec 31, 2024 | -12.69 Mn |
| Sep 30, 2024 | -10.75 Mn |
| Jun 30, 2024 | -11.29 Mn |
| Mar 31, 2024 | -8.81 Mn |